In blood mononuclear cells from T2DM patients, the methylation level at the CpG sites of the monocyte chemoattractant protein (MCP)-1 promoter is decreased, and associated to an overexpression of this chemotactic factor in serum (41). Here, CCL2 is linked to type 2 diabetes mellitus.